u 73122 has been researched along with resveratrol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ando, S; Araki, H; Fukuhara, S; Inagaki, C; Kawai, K; Nakamura, T; Otani, H; Yagi, Y | 1 |
| Chen, JZ; Hu, H; Wang, HQ; Wang, SJ; Wang, XX; Yang, YM | 1 |
| Chen, JZ; Wang, HQ; Wang, SJ; Wang, XX; Yang, YM | 1 |
4 other study(ies) available for u 73122 and resveratrol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Protease-activated receptor 4-mediated Ca2+ signaling in mouse lung alveolar epithelial cells.
Topics: Animals; Calcium; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Estrenes; Gene Expression; Mice; Mice, Inbred C57BL; Oligopeptides; Pulmonary Alveoli; Pyrrolidinones; Receptor, PAR-1; Receptors, Thrombin; Resveratrol; RNA, Messenger; Stilbenes; Thapsigargin; Thrombin | 2007 |
Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Blood Platelets; Blotting, Western; Cardiotonic Agents; Enzyme Inhibitors; Estrenes; Flow Cytometry; Humans; In Vitro Techniques; Isoenzymes; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Pyrrolidinones; Receptors, Thromboxane A2, Prostaglandin H2; Resveratrol; Signal Transduction; Stilbenes; Type C Phospholipases | 2008 |
[Suppressive effect in vitro of resveratrol on ADP induced human platelet aggregation and its active mechanism].
Topics: Adenosine Diphosphate; Blood Platelets; Dose-Response Relationship, Drug; Drug Synergism; Estrenes; Fibrinogen; Humans; Phospholipase C beta; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrrolidinones; Resveratrol; Stilbenes | 2008 |